Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Defibrotide to Reduce Progression of Acute Respiratory Failure Rate in Patients With COVID-19 Pneumonia

NCT04335201 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04335201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04335201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Defibrotide to Reduce Progression of Acute Respiratory Failure Rate in Patients With COVID-19 Pneumonia
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Completed
Start date
May 20, 2020
Completion date
May 28, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with covid-19 pneumonia will allow to detect an absolute reduction in the rate of respiratory-failure